Improving HIV testing and treatment for men in Malawi
Engaging men through HIV self-test and differentiated care models to increase ART initiation and viral suppression in Malawi
This study is all about helping men in Malawi get tested for HIV and start treatment more easily by using home testing kits and personalized care, so they can also support their partners and improve their health together.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10849811 on NIH RePORTER |
What this research studies
This research focuses on increasing HIV testing and treatment among men in Malawi through innovative strategies like home-based HIV self-testing and differentiated care models. It aims to engage men who test positive for HIV by providing them with the tools to test their partners and facilitating their access to antiretroviral therapy (ART) at home. The study will evaluate the effectiveness of these approaches in improving ART initiation and viral suppression rates among men, while also assessing the cost-effectiveness of these interventions. By addressing barriers to care, the research seeks to enhance health outcomes for this underserved population.
Who could benefit from this research
Good fit: Ideal candidates for this research are men in Malawi who have tested positive for HIV through index partner testing.
Not a fit: Patients who are not men or those who do not reside in Malawi may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve HIV treatment initiation and viral suppression rates among men in Malawi, leading to better health outcomes and reduced transmission of the virus.
How similar studies have performed: Previous research has shown success with similar home-based HIV testing and treatment strategies in various settings, indicating potential for positive outcomes in this study.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Dovel, Kathryn L — University of California Los Angeles
- Study coordinator: Dovel, Kathryn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.